2. Academic Validation
  3. Selective and reversible modification of kinase cysteines with chlorofluoroacetamides

Selective and reversible modification of kinase cysteines with chlorofluoroacetamides

  • Nat Chem Biol. 2019 Mar;15(3):250-258. doi: 10.1038/s41589-018-0204-3.
Naoya Shindo 1,  Hirokazu Fuchida 1,  Mami Sato 1,  Kosuke Watari 1,  Tomohiro Shibata 1,  Keiko Kuwata 2,  Chizuru Miura 1,  Kei Okamoto 1,  Yuji Hatsuyama 1,  Keisuke Tokunaga 1,  Seiichi Sakamoto 1,  Satoshi Morimoto 1,  Yoshito Abe 1,  Mitsunori Shiroishi 1,  Jose M M Caaveiro 1,  Tadashi Ueda 1,  Tomonori Tamura 3,  Naoya Matsunaga 1,  Takaharu Nakao 1,  Satoru Koyanagi 1,  Shigehiro Ohdo 1,  Yasuchika Yamaguchi 4,  Itaru Hamachi 3,  Mayumi Ono 1,  Akio Ojida 5
Affiliations

Affiliations

  • 1 Graduate School of Pharmaceutical Sciences, Kyushu University, Fukuoka, Japan.
  • 2 Institute of Transformative Bio-Molecules (WPI-ITbM), Nagoya University, Nagoya, Japan.
  • 3 Graduate School of Engineering, Kyoto University, Kyoto, Japan.
  • 4 Faculty of Pharmaceutical Sciences, Nagasaki International University, Sasebo, Japan.
  • 5 Graduate School of Pharmaceutical Sciences, Kyushu University, Fukuoka, Japan. ojida@phar.kyushu-u.ac.jp.
PMID: 30643284 DOI: 10.1038/s41589-018-0204-3
Abstract

Irreversible inhibition of disease-associated proteins with small molecules is a powerful approach for achieving increased and sustained pharmacological potency. Here, we introduce α-chlorofluoroacetamide (CFA) as a novel warhead of targeted covalent inhibitor (TCI). Despite weak intrinsic reactivity, CFA-appended quinazoline showed high reactivity toward Cys797 of epidermal growth factor receptor (EGFR). In cells, CFA-quinazoline showed higher target specificity for EGFR than the corresponding Michael acceptors in a wide concentration range (0.1-10 μM). The cysteine adduct of the CFA derivative was susceptible to hydrolysis and reversibly yielded intact thiol but was stable in solvent-sequestered ATP-binding pocket of EGFR. This environment-dependent hydrolysis can potentially reduce off-target protein modification by CFA-based drugs. Oral administration of CFA quinazoline NS-062 significantly suppressed tumor growth in a mouse xenograft model. Further, CFA-appended pyrazolopyrimidine irreversibly inhibited Bruton's tyrosine kinase with higher target specificity. These results demonstrate the utility of CFA as a new class warheads for TCI.

Figures
Products
  • Cat. No.
    Product Name
    Description
    Target
    Research Area
  • HY-123891
    EGFR抑制剂
嗨！很高兴为您提供帮助！

尊敬的 MCE 客户您好，
请您选择所在区域，我们将转接对应客服为您服务！

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

热 A B C F G H J L N Q S T X Y Z